Protein & Cell >

2015 , Vol. 6 >Issue 7: 469 - 471

DOI: https://doi.org/10.1007/s13238-015-0170-4

NEWS AND VIEWS

Eliminating residual iPS cells for safety in clinical application

  • Shigeo Masuda ,
  • Shigeru Miyagawa ,
  • Satsuki Fukushima ,
  • Nagako Sougawa ,
  • Kaori Okimoto ,
  • Chika Tada ,
  • Atsuhiro Saito ,
  • Yoshiki Sawa
Expand
  • Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

Published date: 27 Jul 2015

Copyright

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Fold

Cite this article

Shigeo Masuda , Shigeru Miyagawa , Satsuki Fukushima , Nagako Sougawa , Kaori Okimoto , Chika Tada , Atsuhiro Saito , Yoshiki Sawa . Eliminating residual iPS cells for safety in clinical application[J]. Protein & Cell, 2015 , 6(7) : 469 -471 . DOI: 10.1007/s13238-015-0170-4

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Huskey NE (2015) CDK1 inhibition targets the p53-NOXAMCL1 axis, selectively kills embryonic stem cells, and prevents teratoma formation. Stem Cell Rep4: 374-389

DOI

2
Masuda S (2014) Emerging innovation towards safety in the clinical application of ESCs and iPSCs. Nat Rev Cardiol11: 553-554

DOI

3
Tateno H (2011) Glycome diagnosis of human induced pluripotent stem cells using lectin microarray. J Biol Chem286: 20345-20353

DOI

4
Tateno H (2015) Elimination of tumorigenic human pluripotent stem cells by a recombinant lectin-toxin fusion protein. Stem Cell Rep.

DOI

5
Wu T, Pinto HB, Kamikawa YF, Donohoe ME (2015) The BET family member BRD4 interacts with OCT4 and regulates pluripotency gene expression. Stem Cell Rep4: 390-403

DOI

Options
Outlines

/

〈 〉